![]() |
|||||||
|
Fusion Protein:RAF1-EIF3L |
Fusion Gene and Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: RAF1-EIF3L | FusionPDB ID: 71821 | FusionGDB2.0 ID: 71821 | Hgene | Tgene | Gene symbol | RAF1 | EIF3L | Gene ID | 6037 | 51386 |
Gene name | ribonuclease A family member 3 | eukaryotic translation initiation factor 3 subunit L | |
Synonyms | ECP|RAF1|RNS3 | EIF3EIP|EIF3S11|EIF3S6IP|HSPC021|HSPC025|MSTP005 | |
Cytomap | 14q11.2 | 22q13.1 | |
Type of gene | protein-coding | protein-coding | |
Description | eosinophil cationic proteinRNase 3cytotoxic ribonucleaseribonuclease 3ribonuclease, RNase A family, 3 | eukaryotic translation initiation factor 3 subunit LeIEF associated protein HSPC021eukaryotic translation initiation factor 3 subunit 6-interacting proteineukaryotic translation initiation factor 3 subunit E-interacting protein | |
Modification date | 20200313 | 20200322 | |
UniProtAcc | P04049 Main function of 5'-partner protein: FUNCTION: Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). The phosphorylated form of RAF1 (on residues Ser-338 and Ser-339, by PAK1) phosphorylates BAD/Bcl2-antagonist of cell death at 'Ser-75'. Phosphorylates adenylyl cyclases: ADCY2, ADCY5 and ADCY6, resulting in their activation. Phosphorylates PPP1R12A resulting in inhibition of the phosphatase activity. Phosphorylates TNNT2/cardiac muscle troponin T. Can promote NF-kB activation and inhibit signal transducers involved in motility (ROCK2), apoptosis (MAP3K5/ASK1 and STK3/MST2), proliferation and angiogenesis (RB1). Can protect cells from apoptosis also by translocating to the mitochondria where it binds BCL2 and displaces BAD/Bcl2-antagonist of cell death. Regulates Rho signaling and migration, and is required for normal wound healing. Plays a role in the oncogenic transformation of epithelial cells via repression of the TJ protein, occludin (OCLN) by inducing the up-regulation of a transcriptional repressor SNAI2/SLUG, which induces down-regulation of OCLN. Restricts caspase activation in response to selected stimuli, notably Fas stimulation, pathogen-mediated macrophage apoptosis, and erythroid differentiation. {ECO:0000269|PubMed:11427728, ECO:0000269|PubMed:11719507, ECO:0000269|PubMed:15385642, ECO:0000269|PubMed:15618521, ECO:0000269|PubMed:15849194, ECO:0000269|PubMed:16892053, ECO:0000269|PubMed:16924233, ECO:0000269|PubMed:9360956}. | Q9Y262 Main function of 5'-partner protein: FUNCTION: Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis (PubMed:17581632, PubMed:25849773, PubMed:27462815). The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation (PubMed:17581632). The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression (PubMed:25849773). {ECO:0000255|HAMAP-Rule:MF_03011, ECO:0000269|PubMed:17581632, ECO:0000269|PubMed:25849773, ECO:0000269|PubMed:27462815}.; FUNCTION: (Microbial infection) In case of FCV infection, plays a role in the ribosomal termination-reinitiation event leading to the translation of VP2 (PubMed:18056426). {ECO:0000269|PubMed:18056426}. | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000251849, ENST00000442415, ENST00000542177, ENST00000534997, | ENST00000476955, ENST00000381683, ENST00000406934, ENST00000412331, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 24 X 15 X 16=5760 | 10 X 13 X 6=780 |
# samples | 28 | 13 | |
** MAII score | log2(28/5760*10)=-4.36257007938471 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(13/780*10)=-2.58496250072116 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Fusion gene context | PubMed: RAF1 [Title/Abstract] AND EIF3L [Title/Abstract] AND fusion [Title/Abstract] | ||
Fusion neoantigen context | PubMed: RAF1 [Title/Abstract] AND EIF3L [Title/Abstract] AND neoantigen [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | RAF1(12653449)-EIF3L(38282772), # samples:1 RAF1(12660013)-EIF3L(38282771), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | RAF1-EIF3L seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. RAF1-EIF3L seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. RAF1-EIF3L seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF. RAF1-EIF3L seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. RAF1-EIF3L seems lost the major protein functional domain in Hgene partner, which is a kinase due to the frame-shifted ORF. RAF1-EIF3L seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | RAF1 | GO:0002227 | innate immune response in mucosa | 12860195 |
Hgene | RAF1 | GO:0019731 | antibacterial humoral response | 12860195 |
Hgene | RAF1 | GO:0043152 | induction of bacterial agglutination | 23992292 |
Hgene | RAF1 | GO:0045087 | innate immune response | 23992292 |
Hgene | RAF1 | GO:0050829 | defense response to Gram-negative bacterium | 23992292 |
Hgene | RAF1 | GO:0050830 | defense response to Gram-positive bacterium | 12860195|23992292 |
Hgene | RAF1 | GO:0061844 | antimicrobial humoral immune response mediated by antimicrobial peptide | 12860195 |
Tgene | EIF3L | GO:0006413 | translational initiation | 17581632 |
Tgene | EIF3L | GO:0075525 | viral translational termination-reinitiation | 21347434 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr3:12653449/chr22:38282772) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Amino Acid Sequences |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000251849 | RAF1 | chr3 | 12653449 | - | ENST00000412331 | EIF3L | chr22 | 38282772 | + | 1823 | 760 | 1036 | 1425 | 129 |
ENST00000251849 | RAF1 | chr3 | 12653449 | - | ENST00000381683 | EIF3L | chr22 | 38282772 | + | 895 | 760 | 440 | 766 | 108 |
ENST00000251849 | RAF1 | chr3 | 12653449 | - | ENST00000406934 | EIF3L | chr22 | 38282772 | + | 1046 | 760 | 440 | 766 | 108 |
ENST00000442415 | RAF1 | chr3 | 12653449 | - | ENST00000412331 | EIF3L | chr22 | 38282772 | + | 1745 | 682 | 958 | 1347 | 129 |
ENST00000442415 | RAF1 | chr3 | 12653449 | - | ENST00000381683 | EIF3L | chr22 | 38282772 | + | 817 | 682 | 362 | 688 | 108 |
ENST00000442415 | RAF1 | chr3 | 12653449 | - | ENST00000406934 | EIF3L | chr22 | 38282772 | + | 968 | 682 | 362 | 688 | 108 |
ENST00000542177 | RAF1 | chr3 | 12660013 | - | ENST00000412331 | EIF3L | chr22 | 38282771 | + | 1601 | 538 | 814 | 1203 | 129 |
ENST00000542177 | RAF1 | chr3 | 12660013 | - | ENST00000381683 | EIF3L | chr22 | 38282771 | + | 673 | 538 | 331 | 657 | 108 |
ENST00000542177 | RAF1 | chr3 | 12660013 | - | ENST00000406934 | EIF3L | chr22 | 38282771 | + | 824 | 538 | 331 | 657 | 108 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000251849 | ENST00000412331 | RAF1 | chr3 | 12653449 | - | EIF3L | chr22 | 38282772 | + | 0.111720696 | 0.8882793 |
ENST00000251849 | ENST00000381683 | RAF1 | chr3 | 12653449 | - | EIF3L | chr22 | 38282772 | + | 0.08490209 | 0.9150979 |
ENST00000251849 | ENST00000406934 | RAF1 | chr3 | 12653449 | - | EIF3L | chr22 | 38282772 | + | 0.10861428 | 0.8913857 |
ENST00000442415 | ENST00000412331 | RAF1 | chr3 | 12653449 | - | EIF3L | chr22 | 38282772 | + | 0.11684319 | 0.8831568 |
ENST00000442415 | ENST00000381683 | RAF1 | chr3 | 12653449 | - | EIF3L | chr22 | 38282772 | + | 0.123146296 | 0.8768537 |
ENST00000442415 | ENST00000406934 | RAF1 | chr3 | 12653449 | - | EIF3L | chr22 | 38282772 | + | 0.148866 | 0.851134 |
ENST00000542177 | ENST00000412331 | RAF1 | chr3 | 12660013 | - | EIF3L | chr22 | 38282771 | + | 0.042564526 | 0.9574354 |
ENST00000542177 | ENST00000381683 | RAF1 | chr3 | 12660013 | - | EIF3L | chr22 | 38282771 | + | 0.04913119 | 0.9508688 |
ENST00000542177 | ENST00000406934 | RAF1 | chr3 | 12660013 | - | EIF3L | chr22 | 38282771 | + | 0.05760638 | 0.94239366 |
![]() |
Get the fusion protein sequences from here. |
Fusion protein sequence information is available in the fasta format. >FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP |
Top |
Fusion Protein Breakpoint Sequences for RAF1-EIF3L |
![]() |
Hgene | Hchr | Hbp | Tgene | Tchr | Tbp | Length(fusion protein) | BP in fusion protein | Peptide |
RAF1 | chr3 | 12653449 | EIF3L | chr22 | 38282772 | 682 | 41 | FRIHQLLVFKLSYFYFVLLRWSLTLS |
RAF1 | chr3 | 12653449 | EIF3L | chr22 | 38282772 | 760 | 41 | FRIHQLLVFKLSYFYFVLLRWSLTLS |
RAF1 | chr3 | 12660013 | EIF3L | chr22 | 38282771 | 538 | 41 | FRIHQLLVFKLSYFYFVLLRWSLTLS |
RAF1 | chr3 | 12660013 | EIF3L | chr22 | 38282771 | 538 | 69 | TIRVFLPNKQRTVDMIHIADTKVARR |
Top |
Potential FusionNeoAntigen Information of RAF1-EIF3L in HLA I |
![]() |
RAF1-EIF3L_12653449_38282772.msa | |
RAF1-EIF3L_12660013_38282771.msa |
![]() * We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5) |
Fusion gene | Hchr | Hbp | Tgene | Tchr | Tbp | HLA I | FusionNeoAntigen peptide | Binding score | Immunogenic score | Neoantigen start (at BP 13) | Neoantigen end (at BP 13) |
RAF1-EIF3L | chr3 | 12653449 | chr22 | 38282772 | 760 | HLA-B15:17 | LVFKLSYFY | 0.9769 | 0.6531 | 6 | 15 |
RAF1-EIF3L | chr3 | 12653449 | chr22 | 38282772 | 760 | HLA-B15:02 | LVFKLSYFY | 0.9605 | 0.7741 | 6 | 15 |
RAF1-EIF3L | chr3 | 12653449 | chr22 | 38282772 | 760 | HLA-A02:04 | KLSYFYFVL | 0.9503 | 0.6916 | 9 | 18 |
RAF1-EIF3L | chr3 | 12653449 | chr22 | 38282772 | 760 | HLA-A31:08 | YFYFVLLRW | 0.9401 | 0.5925 | 12 | 21 |
RAF1-EIF3L | chr3 | 12653449 | chr22 | 38282772 | 760 | HLA-A31:02 | SYFYFVLLR | 0.9339 | 0.5886 | 11 | 20 |
RAF1-EIF3L | chr3 | 12653449 | chr22 | 38282772 | 760 | HLA-A32:13 | LVFKLSYFY | 0.7176 | 0.7425 | 6 | 15 |
RAF1-EIF3L | chr3 | 12653449 | chr22 | 38282772 | 760 | HLA-A31:08 | SYFYFVLLRW | 0.9608 | 0.573 | 11 | 21 |
RAF1-EIF3L | chr3 | 12653449 | chr22 | 38282772 | 760 | HLA-A31:01 | SYFYFVLLR | 0.9654 | 0.5707 | 11 | 20 |
RAF1-EIF3L | chr3 | 12653449 | chr22 | 38282772 | 760 | HLA-B15:05 | LVFKLSYFY | 0.9507 | 0.5992 | 6 | 15 |
RAF1-EIF3L | chr3 | 12653449 | chr22 | 38282772 | 760 | HLA-B15:31 | LVFKLSYFY | 0.9185 | 0.6155 | 6 | 15 |
RAF1-EIF3L | chr3 | 12653449 | chr22 | 38282772 | 760 | HLA-B15:20 | LVFKLSYFY | 0.9633 | 0.7142 | 6 | 15 |
RAF1-EIF3L | chr3 | 12653449 | chr22 | 38282772 | 760 | HLA-A32:01 | KLSYFYFVL | 0.941 | 0.9575 | 9 | 18 |
RAF1-EIF3L | chr3 | 12653449 | chr22 | 38282772 | 760 | HLA-B35:28 | LVFKLSYFY | 0.9285 | 0.6989 | 6 | 15 |
RAF1-EIF3L | chr3 | 12653449 | chr22 | 38282772 | 760 | HLA-B35:23 | LVFKLSYFY | 0.9264 | 0.6755 | 6 | 15 |
RAF1-EIF3L | chr3 | 12653449 | chr22 | 38282772 | 760 | HLA-B35:20 | LVFKLSYFY | 0.9114 | 0.7243 | 6 | 15 |
RAF1-EIF3L | chr3 | 12653449 | chr22 | 38282772 | 760 | HLA-A32:01 | LVFKLSYFY | 0.8697 | 0.8564 | 6 | 15 |
RAF1-EIF3L | chr3 | 12653449 | chr22 | 38282772 | 760 | HLA-B35:24 | LVFKLSYFY | 0.8466 | 0.8222 | 6 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | HLA-A30:08 | RTVDMIHIA | 0.9693 | 0.6766 | 10 | 19 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | HLA-B15:07 | KQRTVDMIH | 0.9692 | 0.6243 | 8 | 17 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | HLA-B15:04 | KQRTVDMIH | 0.8759 | 0.8618 | 8 | 17 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | HLA-C01:17 | FLPNKQRTVDM | 0.9756 | 0.8968 | 4 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | HLA-C01:30 | FLPNKQRTVDM | 0.9647 | 0.9414 | 4 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | HLA-B15:50 | KQRTVDMIH | 0.9875 | 0.8214 | 8 | 17 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | HLA-B15:35 | KQRTVDMIH | 0.9671 | 0.834 | 8 | 17 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | HLA-B15:68 | KQRTVDMIH | 0.5115 | 0.5301 | 8 | 17 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | HLA-C01:02 | FLPNKQRTVDM | 0.9759 | 0.8941 | 4 | 15 |
Top |
Potential FusionNeoAntigen Information of RAF1-EIF3L in HLA II |
![]() |
RAF1-EIF3L_12660013_38282771.msa |
![]() * We used NetMHCIIpan v4.1 (%rank<0.5). |
Fusion gene | Hchr | Hbp | Tgene | Tchr | Tbp | HLA II | FusionNeoAntigen peptide | Neoantigen start (at BP 13) | Neoantigen end (at BP 13) |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0338 | IRVFLPNKQRTVDMI | 1 | 16 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0338 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0403 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0413 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0415 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0415 | RTVDMIHIADTKVAR | 10 | 25 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0419 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0422 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0427 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0427 | RTVDMIHIADTKVAR | 10 | 25 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0431 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0436 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0436 | RTVDMIHIADTKVAR | 10 | 25 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0437 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0437 | RTVDMIHIADTKVAR | 10 | 25 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0439 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0440 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0441 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0442 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0444 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0446 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0447 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0449 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0450 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0450 | RTVDMIHIADTKVAR | 10 | 25 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0451 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0452 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0453 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0453 | RTVDMIHIADTKVAR | 10 | 25 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0454 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0455 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0455 | RTVDMIHIADTKVAR | 10 | 25 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0456 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0458 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0458 | RTVDMIHIADTKVAR | 10 | 25 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0459 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0460 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0461 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0465 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0465 | RTVDMIHIADTKVAR | 10 | 25 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0468 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0470 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0471 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0473 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0473 | RTVDMIHIADTKVAR | 10 | 25 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0475 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0478 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0478 | RTVDMIHIADTKVAR | 10 | 25 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0479 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0485 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0488 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0902 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-0906 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1114 | IRVFLPNKQRTVDMI | 1 | 16 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1114 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1120 | IRVFLPNKQRTVDMI | 1 | 16 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1120 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1168 | IRVFLPNKQRTVDMI | 1 | 16 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1168 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1302 | IRVFLPNKQRTVDMI | 1 | 16 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1302 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1323 | IRVFLPNKQRTVDMI | 1 | 16 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1323 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1329 | IRVFLPNKQRTVDMI | 1 | 16 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1329 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1331 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1331 | IRVFLPNKQRTVDMI | 1 | 16 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1331 | RVFLPNKQRTVDMIH | 2 | 17 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1334 | IRVFLPNKQRTVDMI | 1 | 16 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1334 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1336 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1336 | IRVFLPNKQRTVDMI | 1 | 16 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1339 | IRVFLPNKQRTVDMI | 1 | 16 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1339 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1341 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1341 | IRVFLPNKQRTVDMI | 1 | 16 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1367 | IRVFLPNKQRTVDMI | 1 | 16 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1367 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1373 | IRVFLPNKQRTVDMI | 1 | 16 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1373 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1374 | IRVFLPNKQRTVDMI | 1 | 16 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1374 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1396 | IRVFLPNKQRTVDMI | 1 | 16 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1396 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1396 | RVFLPNKQRTVDMIH | 2 | 17 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1397 | IRVFLPNKQRTVDMI | 1 | 16 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1397 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1399 | IRVFLPNKQRTVDMI | 1 | 16 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1399 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1410 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1410 | RTVDMIHIADTKVAR | 10 | 25 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1424 | IRVFLPNKQRTVDMI | 1 | 16 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1424 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1447 | IRVFLPNKQRTVDMI | 1 | 16 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1447 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1448 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1448 | IRVFLPNKQRTVDMI | 1 | 16 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1449 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1452 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1457 | TVDMIHIADTKVARR | 11 | 26 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1457 | RTVDMIHIADTKVAR | 10 | 25 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1493 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1493 | IRVFLPNKQRTVDMI | 1 | 16 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1498 | IRVFLPNKQRTVDMI | 1 | 16 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1498 | TIRVFLPNKQRTVDM | 0 | 15 |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 | DRB1-1615 | TVDMIHIADTKVARR | 11 | 26 |
Top |
Fusion breakpoint peptide structures of RAF1-EIF3L |
![]() * The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA. |
File name | BPseq | Hgene | Tgene | Hchr | Hbp | Tchr | Tbp | AAlen |
5773 | LVFKLSYFYFVLLR | RAF1 | EIF3L | chr3 | 12653449 | chr22 | 38282772 | 760 |
File name | BPseq | Hgene | Tgene | Hchr | Hbp | Tchr | Tbp | AAlen |
6828 | PNKQRTVDMIHIAD | RAF1 | EIF3L | chr3 | 12660013 | chr22 | 38282771 | 538 |
Top |
Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of RAF1-EIF3L |
![]() * We used Glide to predict the interaction between HLAs and neoantigens. |
HLA allele | PDB ID | File name | BPseq | Docking score | Glide score |
HLA-B14:02 | 3BVN | 5773 | LVFKLSYFYFVLLR | -7.18567 | -7.19287 |
HLA-B52:01 | 3W39 | 5773 | LVFKLSYFYFVLLR | -5.78907 | -5.79627 |
HLA-A11:01 | 4UQ2 | 5773 | LVFKLSYFYFVLLR | -5.50944 | -5.51664 |
HLA-A24:02 | 5HGA | 5773 | LVFKLSYFYFVLLR | -9.02521 | -9.03241 |
HLA-B44:05 | 3DX8 | 5773 | LVFKLSYFYFVLLR | -6.20133 | -6.20853 |
HLA-B14:02 | 3BVN | 6828 | PNKQRTVDMIHIAD | -7.4919 | -7.6872 |
HLA-B14:02 | 3BVN | 6828 | PNKQRTVDMIHIAD | -3.50241 | -4.25761 |
HLA-B52:01 | 3W39 | 6828 | PNKQRTVDMIHIAD | -5.86771 | -6.06301 |
HLA-B52:01 | 3W39 | 6828 | PNKQRTVDMIHIAD | -3.79774 | -4.55294 |
HLA-A11:01 | 4UQ2 | 6828 | PNKQRTVDMIHIAD | -7.50206 | -7.69736 |
HLA-A11:01 | 4UQ2 | 6828 | PNKQRTVDMIHIAD | -1.62616 | -2.38136 |
HLA-A24:02 | 5HGA | 6828 | PNKQRTVDMIHIAD | -7.66017 | -8.41537 |
HLA-A24:02 | 5HGA | 6828 | PNKQRTVDMIHIAD | -7.27715 | -7.47245 |
HLA-B27:05 | 6PYJ | 6828 | PNKQRTVDMIHIAD | -5.33187 | -5.52717 |
HLA-B44:05 | 3DX8 | 6828 | PNKQRTVDMIHIAD | -6.52338 | -6.71868 |
HLA-B44:05 | 3DX8 | 6828 | PNKQRTVDMIHIAD | -4.6191 | -5.3743 |
HLA-A02:01 | 6TDR | 6828 | PNKQRTVDMIHIAD | -1.87587 | -2.07117 |
Top |
Vaccine Design for the FusionNeoAntigens of RAF1-EIF3L |
![]() |
Fusion gene | Hchr | Hbp | Tchr | Tbp | Start in +/-13AA | End in +/-13AA | FusionNeoAntigen peptide sequence | FusionNeoAntigen RNA sequence |
RAF1-EIF3L | chr3 | 12653449 | chr22 | 38282772 | 11 | 20 | SYFYFVLLR | CAAAGGGACATGATCCACATCGCGGAC |
RAF1-EIF3L | chr3 | 12653449 | chr22 | 38282772 | 11 | 21 | SYFYFVLLRW | CAAAGGGACATGATCCACATCGCGGACACC |
RAF1-EIF3L | chr3 | 12653449 | chr22 | 38282772 | 12 | 21 | YFYFVLLRW | AGGGACATGATCCACATCGCGGACACC |
RAF1-EIF3L | chr3 | 12653449 | chr22 | 38282772 | 6 | 15 | LVFKLSYFY | ACTTCTCCACGAACACAAAGGGACATG |
RAF1-EIF3L | chr3 | 12653449 | chr22 | 38282772 | 9 | 18 | KLSYFYFVL | CGAACACAAAGGGACATGATCCACATC |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 10 | 19 | RTVDMIHIA | AGAACAGTGGACATGATCCACATCGCG |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 4 | 15 | FLPNKQRTVDM | TTCTTGCCGAACAAGCAAAGAACAGTGGACATG |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 8 | 17 | KQRTVDMIH | AAGCAAAGAACAGTGGACATGATCCAC |
![]() |
Fusion gene | Hchr | Hbp | Tchr | Tbp | Start in +/-13AA | End in +/-13AA | FusionNeoAntigen peptide | FusionNEoAntigen RNA sequence |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 0 | 15 | TIRVFLPNKQRTVDM | ACTATCCGTGTTTTCTTGCCGAACAAGCAAAGAACAGTGGACATG |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 1 | 16 | IRVFLPNKQRTVDMI | ATCCGTGTTTTCTTGCCGAACAAGCAAAGAACAGTGGACATGATC |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 10 | 25 | RTVDMIHIADTKVAR | AGAACAGTGGACATGATCCACATCGCGGACACCAAGGTCGCCAGG |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 11 | 26 | TVDMIHIADTKVARR | ACAGTGGACATGATCCACATCGCGGACACCAAGGTCGCCAGGCGT |
RAF1-EIF3L | chr3 | 12660013 | chr22 | 38282771 | 2 | 17 | RVFLPNKQRTVDMIH | CGTGTTTTCTTGCCGAACAAGCAAAGAACAGTGGACATGATCCAC |
Top |
Information of the samples that have these potential fusion neoantigens of RAF1-EIF3L |
![]() |
Cancer type | Fusion gene | Hchr | Hbp | Henst | Tchr | Tbp | Tenst | Sample |
DLBC | RAF1-EIF3L | chr3 | 12653449 | ENST00000251849 | chr22 | 38282772 | ENST00000412331 | TCGA-G8-6325-01A |
DLBC | RAF1-EIF3L | chr3 | 12660013 | ENST00000542177 | chr22 | 38282771 | ENST00000381683 | TCGA-G8-6325 |
Top |
Potential target of CAR-T therapy development for RAF1-EIF3L |
![]() |
![]() * Minus value of BPloci means that the break point is located before the CDS. |
- In-frame and retained 'Transmembrane'. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
![]() * We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image. |
Hgene | Hchr | Hbp | Henst | Tgene | Tchr | Tbp | Tenst | DeepLoc result |
Top |
Related Drugs to RAF1-EIF3L |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to RAF1-EIF3L |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | RAF1 | C0028326 | Noonan Syndrome | 10 | CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET |
Hgene | RAF1 | C0175704 | LEOPARD Syndrome | 7 | CLINGEN;CTD_human;GENOMICS_ENGLAND |
Hgene | RAF1 | C1969057 | Noonan Syndrome 5 | 4 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | RAF1 | C1969056 | LEOPARD SYNDROME 2 | 3 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | RAF1 | C0007194 | Hypertrophic Cardiomyopathy | 2 | CTD_human |
Hgene | RAF1 | C0041409 | Turner Syndrome, Male | 2 | CTD_human |
Hgene | RAF1 | C1519086 | Pilomyxoid astrocytoma | 2 | ORPHANET |
Hgene | RAF1 | C1527404 | Female Pseudo-Turner Syndrome | 2 | CTD_human |
Hgene | RAF1 | C4551472 | Hypertrophic obstructive cardiomyopathy | 2 | CTD_human |
Hgene | RAF1 | C4551602 | Noonan Syndrome 1 | 2 | CTD_human |
Hgene | RAF1 | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
Hgene | RAF1 | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
Hgene | RAF1 | C0007193 | Cardiomyopathy, Dilated | 1 | CTD_human |
Hgene | RAF1 | C0017638 | Glioma | 1 | CTD_human |
Hgene | RAF1 | C0020429 | Hyperalgesia | 1 | CTD_human |
Hgene | RAF1 | C0022665 | Kidney Neoplasm | 1 | CTD_human |
Hgene | RAF1 | C0023903 | Liver neoplasms | 1 | CTD_human |
Hgene | RAF1 | C0024121 | Lung Neoplasms | 1 | CTD_human |
Hgene | RAF1 | C0242379 | Malignant neoplasm of lung | 1 | CTD_human |
Hgene | RAF1 | C0259783 | mixed gliomas | 1 | CTD_human |
Hgene | RAF1 | C0340427 | Familial dilated cardiomyopathy | 1 | ORPHANET |
Hgene | RAF1 | C0345904 | Malignant neoplasm of liver | 1 | CTD_human |
Hgene | RAF1 | C0345967 | Malignant mesothelioma | 1 | CTD_human |
Hgene | RAF1 | C0458247 | Allodynia | 1 | CTD_human |
Hgene | RAF1 | C0555198 | Malignant Glioma | 1 | CTD_human |
Hgene | RAF1 | C0587248 | Costello syndrome (disorder) | 1 | CLINGEN |
Hgene | RAF1 | C0678222 | Breast Carcinoma | 1 | CTD_human |
Hgene | RAF1 | C0740457 | Malignant neoplasm of kidney | 1 | CTD_human |
Hgene | RAF1 | C0751211 | Hyperalgesia, Primary | 1 | CTD_human |
Hgene | RAF1 | C0751212 | Hyperalgesia, Secondary | 1 | CTD_human |
Hgene | RAF1 | C0751213 | Tactile Allodynia | 1 | CTD_human |
Hgene | RAF1 | C0751214 | Hyperalgesia, Thermal | 1 | CTD_human |
Hgene | RAF1 | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
Hgene | RAF1 | C1275081 | Cardio-facio-cutaneous syndrome | 1 | CLINGEN |
Hgene | RAF1 | C1449563 | Cardiomyopathy, Familial Idiopathic | 1 | CTD_human |
Hgene | RAF1 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Hgene | RAF1 | C2936719 | Mechanical Allodynia | 1 | CTD_human |
Hgene | RAF1 | C4014656 | CARDIOMYOPATHY, DILATED, 1NN | 1 | CTD_human;UNIPROT |
Hgene | RAF1 | C4551484 | Leopard Syndrome 1 | 1 | CTD_human;GENOMICS_ENGLAND |
Hgene | RAF1 | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |
Hgene | RAF1 | C4721610 | Carcinoma, Ovarian Epithelial | 1 | CTD_human |